Columbia University pulmonologists conducts clinical trial on novel triple combination modulator for cystic fibrosis in patients with advanced lung disease, demonstrating progressive improvement in weight, lung function, and patient-reported outcomes.

Pulmonologists at NewYork-Presbyterian/Weill Cornell Medical Center are developing a new paradigm to confront idiopathic pulmonary fibrosis (IPF) and other forms of progressive fibrotic ILDs.

Dr. Garcia’s research utilizes next generation sequencing and bioinformatic analyses to identify rare mutations in genes linked to inherited forms of lung disease.

To assist intensive care unit survivors in their recuperation, the Division of Pulmonary and Critical Care Medicine at NewYork-Presbyterian/Weill Cornell Medical Center established a Post-ICU Recovery Clinic.

Christine Kim Garcia, MD, PhD, joined NewYork-Presbyterian/Columbia University Irving Medical Center as Associate Chief of the Division of Pulmonary, Allergy, and Critical Care Medicine in January 2019.

While trained to save the lives of the critically ill, these physicians must also have the skills and knowledge to provide palliative care to the patient and emotional support for the family when end of life is inevitable.

Sleep is increasingly recognized as an important contributor to health, yet many Americans regularly do not get enough sleep. To learn if inadequate sleep increases their risks of heart disease, NYP Columbia study the relationship between sleep habits and cardiovascular risk factors.

Despite years of investigations, the origin of idiopathic pulmonary fibrosis has remained elusive. Researchers at NewYork-Presbyterian/Weill Cornell are looking into new therapies to slow the progression.